Clinical trial
Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of a Therapeutic Administration of Selenium, as Selenite, in Septic Shock Patients.
NCT00207844 is registered in ClinicalTrials.gov with Centre Hospitalier de Meaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of a Therapeutic Administration of Selenium, as Selenite, in Septic Shock Patients.
- Lead sponsor
- Centre Hospitalier de Meaux
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2002
- Completion date
- January 31, 2005
- Enrollment
- 60
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock, severe sepsis